These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6371017)

  • 1. Chemotherapy in advanced ovarian cancer.
    Rodenburg CJ; Cleton FJ
    J Cancer Res Clin Oncol; 1984; 107(2):99-105. PubMed ID: 6371017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary chemotherapy in advanced ovarian cancer--new drugs].
    Bruntsch U
    Onkologie; 1985 Dec; 8(6):410-6. PubMed ID: 3912697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line chemotherapy for ovarian cancer.
    Weiss GR
    Clin Obstet Gynecol; 1986 Sep; 29(3):665-77. PubMed ID: 3757343
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of advanced epithelial ovarian carcinoma].
    Meerpohl HG
    Onkologie; 1984 May; 7 Suppl 2():22-34. PubMed ID: 6431349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present optimal therapy in ovarian cancer.
    Abrams J
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):9-12. PubMed ID: 3082643
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy of ovarian carcinoma: an overview.
    Thigpen T; Blessing JA
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):47-52. PubMed ID: 4048976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy as primary therapy in non-radically operated ovarian cancer].
    Brunner KW; Goldhirsch A; Greiner R
    Onkologie; 1985 Dec; 8(6):347-55. PubMed ID: 2419812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
    Piver MS; Recio FO; Baker TR; Driscoll D
    Cancer; 1994 Mar; 73(6):1693-8. PubMed ID: 7512437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal chemotherapy in ovarian cancer: who and when?
    Tournigand C
    Curr Opin Obstet Gynecol; 2005 Feb; 17(1):83-6. PubMed ID: 15711417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
    Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
    J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.